ES499261A0 - Procedimiento para la preparacion de un plasmido que codifica para la secuencia de aminoacidos del interferon de leuco- citos humanos. - Google Patents

Procedimiento para la preparacion de un plasmido que codifica para la secuencia de aminoacidos del interferon de leuco- citos humanos.

Info

Publication number
ES499261A0
ES499261A0 ES499261A ES499261A ES499261A0 ES 499261 A0 ES499261 A0 ES 499261A0 ES 499261 A ES499261 A ES 499261A ES 499261 A ES499261 A ES 499261A ES 499261 A0 ES499261 A0 ES 499261A0
Authority
ES
Spain
Prior art keywords
interferon
plasmid
codes
leukocytes
cdna
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES499261A
Other languages
English (en)
Other versions
ES8205431A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoechst AG
Original Assignee
Hoechst AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst AG filed Critical Hoechst AG
Publication of ES499261A0 publication Critical patent/ES499261A0/es
Publication of ES8205431A1 publication Critical patent/ES8205431A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1003Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52Cytokines; Lymphokines; Interferons
    • C07K14/555Interferons [IFN]
    • C07K14/56IFN-alpha

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ES499261A 1980-02-16 1981-02-10 Procedimiento para la preparacion de un plasmido que codifica para la secuencia de aminoacidos del interferon de leuco- citos humanos. Expired ES8205431A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19803005897 DE3005897A1 (de) 1980-02-16 1980-02-16 Genprodukt eines hoeheren organismus aus einem dieses gen enhtaltenden mikroorganismus

Publications (2)

Publication Number Publication Date
ES499261A0 true ES499261A0 (es) 1982-06-01
ES8205431A1 ES8205431A1 (es) 1982-06-01

Family

ID=6094832

Family Applications (3)

Application Number Title Priority Date Filing Date
ES499261A Expired ES8205431A1 (es) 1980-02-16 1981-02-10 Procedimiento para la preparacion de un plasmido que codifica para la secuencia de aminoacidos del interferon de leuco- citos humanos.
ES499262A Expired ES8205428A1 (es) 1980-02-16 1981-02-10 Procedimiento para la obtencion de un microorganismo que forma un polipetido con la secuencia de aminoacidos del inter- feron de leucocitos humanos.
ES499259A Expired ES8301502A1 (es) 1980-02-16 1981-02-10 Procedimiento para la preparacion microbiologica de un polipeptido que contiene total o parcialmente la secuencia de a- minoacidos del interferon de leucocitos humanos.

Family Applications After (2)

Application Number Title Priority Date Filing Date
ES499262A Expired ES8205428A1 (es) 1980-02-16 1981-02-10 Procedimiento para la obtencion de un microorganismo que forma un polipetido con la secuencia de aminoacidos del inter- feron de leucocitos humanos.
ES499259A Expired ES8301502A1 (es) 1980-02-16 1981-02-10 Procedimiento para la preparacion microbiologica de un polipeptido que contiene total o parcialmente la secuencia de a- minoacidos del interferon de leucocitos humanos.

Country Status (13)

Country Link
EP (1) EP0034307B1 (es)
JP (1) JPS56158793A (es)
AT (1) ATE26463T1 (es)
AU (1) AU6728881A (es)
BE (1) BE887529A (es)
DE (2) DE3005897A1 (es)
ES (3) ES8205431A1 (es)
FR (1) FR2478124A1 (es)
GB (1) GB2071108A (es)
IT (1) IT1141977B (es)
NL (1) NL8100718A (es)
SE (1) SE8101005L (es)
ZA (1) ZA81975B (es)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2687995B2 (ja) 1980-04-03 1997-12-08 バイオゲン インコーポレイテッド Dna配列、組替えdna分子およびヒト繊維芽細胞インターフェロン様ポリペプチドの製造方法
EP0042246B1 (en) * 1980-06-12 1987-03-18 The Cancer Institute Of Japanese Foundation For Cancer Research Plasmid
CH657141A5 (de) * 1980-07-01 1986-08-15 Hoffmann La Roche Dns-sequenzen, rekombinante expressionsvektoren zur mikrobiellen herstellung von human-leukozyten-interferonen und transformierte mikroorganismen.
GB2108510B (en) * 1981-10-03 1984-12-12 Ciba Geigy Ag Dnas, recombinant dnas, hosts containing them, polypeptides and processes for the production thereof
US5582824A (en) * 1981-10-19 1996-12-10 Genentech, Inc. Recombinant DES-CYS-TYR-CYS human immune interferon
AU561343B2 (en) * 1981-10-19 1987-05-07 Genentech Inc. Human immune interferon by recombinant dna
JPS58110548A (ja) * 1981-12-24 1983-07-01 Asahi Chem Ind Co Ltd 新規な生理活性ペプチド
JPS58116498A (ja) * 1981-12-28 1983-07-11 Takeda Chem Ind Ltd Il‐2をコードする新規伝令rnaの製造法
US4450103A (en) * 1982-03-01 1984-05-22 Cetus Corporation Process for recovering human IFN-β from a transformed microorganism
IE54592B1 (en) * 1982-03-08 1989-12-06 Genentech Inc Anumal interferons, processes involved in their production, compositions containing them, dna sequences coding therefor and espression vehicles containing such sequences and cells transformed thereby
US6432677B1 (en) 1982-03-08 2002-08-13 Genentech, Inc. Non-human animal interferons
US5827694A (en) * 1982-03-08 1998-10-27 Genentech, Inc. DNA encoding non-human animal interferons, vectors and hosts therefor, and recombinant production of IFN polypeptides
US6936694B1 (en) 1982-05-06 2005-08-30 Intermune, Inc. Manufacture and expression of large structural genes
DE3220116A1 (de) * 1982-05-28 1983-12-01 Dr. Karl Thomae Gmbh, 7950 Biberach Mikrobiologisch hergestellte (alpha)- und ss-interferone, dna-sequenzen, die fuer diese interferone codieren, mikroorganismen, die diese genetische information enthalten, und verfahren zu ihrer herstellung
US5831023A (en) * 1982-11-01 1998-11-03 Genentech, Inc. Recombinant animal interferon polypeptides
ZA846554B (en) * 1983-09-20 1985-04-24 Hoffmann La Roche Immune interferon and method for its purification
MX9203641A (es) * 1983-12-16 1992-07-01 Genentech Inc Interferones gamma recombinantes que poseen estabilidad mejorada y metodos biotecnologicos para su obtencion.
US4855238A (en) * 1983-12-16 1989-08-08 Genentech, Inc. Recombinant gamma interferons having enhanced stability and methods therefor
SU1364343A1 (ru) * 1984-07-13 1988-01-07 Всесоюзный научно-исследовательский институт генетики и селекции промышленных микроорганизмов Способ получени человеческого лейкоцитарного интерферона альфа-2
EP0859633A2 (en) * 1996-08-16 1998-08-26 Kurt B. Osther Method for treating diabetes
US6887462B2 (en) 2001-04-09 2005-05-03 Chiron Corporation HSA-free formulations of interferon-beta
ES2856881T3 (es) 2005-04-11 2021-09-28 Horizon Pharma Rheumatology Llc Formas variantes de urato oxidasa y su uso
ES2532804T3 (es) 2006-04-12 2015-03-31 Crealta Pharmaceuticals Llc Purificación de proteínas con tensioactivo catiónico
US8273561B2 (en) 2007-10-05 2012-09-25 Nuron Biotech, Inc. High pressure treatment of aggregated interferons
AU2010265964B2 (en) 2009-06-25 2014-09-18 Horizon Therapeutics Usa, Inc. Methods and kits for predicting infusion reaction risk and antibody-mediated loss of response by monitoring serum uric acid during PEGylated uricase therapy

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI77877C (fi) * 1979-04-20 1989-05-10 Technobiotic Ltd Foerfarande foer framstaellning och rening av human le-formig interferonprotein.
AU538665B2 (en) * 1979-10-30 1984-08-23 Juridical Foundation, Japanese Foundation For Cancer Research Human interferon dna
IL58765A (en) * 1979-11-21 1986-09-30 Yeda Res & Dev Process for the production of essentially pure messenger rna of human fibroblast interferon and process for the production of interferon beta
NZ195980A (en) * 1980-01-08 1984-10-19 Biogen Nv Dna sequences,recombinant dna molecules and processes for producing leukocyte interferon-like polypeptides;pharmaceutical and veterinary compositions
DK33181A (da) * 1980-02-06 1981-08-07 Searle & Co Fremgangsmaade til fremstilling af et interferonlignende protein

Also Published As

Publication number Publication date
AU6728881A (en) 1981-08-27
ES499262A0 (es) 1982-06-01
EP0034307A2 (de) 1981-08-26
IT1141977B (it) 1986-10-08
ZA81975B (en) 1982-03-31
EP0034307A3 (en) 1981-11-18
DE3005897A1 (de) 1981-09-03
ES499259A0 (es) 1982-12-01
ATE26463T1 (de) 1987-04-15
GB2071108A (en) 1981-09-16
FR2478124A1 (fr) 1981-09-18
ES8205431A1 (es) 1982-06-01
ES8205428A1 (es) 1982-06-01
EP0034307B1 (de) 1987-04-08
JPS56158793A (en) 1981-12-07
BE887529A (fr) 1981-08-17
IT8119760A0 (it) 1981-02-13
ES8301502A1 (es) 1982-12-01
NL8100718A (nl) 1981-09-16
DE3176088D1 (en) 1987-05-14
SE8101005L (sv) 1981-08-17

Similar Documents

Publication Publication Date Title
ES499261A0 (es) Procedimiento para la preparacion de un plasmido que codifica para la secuencia de aminoacidos del interferon de leuco- citos humanos.
GB2090258B (en) Hybrid leukocyte interferon
UA39161C2 (uk) Рекомбінантний білок gm-csf для збільшення продукції гранулоцитів і макрофагів у пацієнтів, вектор і кднк, що його кодують
IL68790A0 (en) Microbiologically produced alpha-and beta-interferons,dna sequences which code for these interferons,microorganisms which contain this genetic information and their preparation
IE811463L (en) Interferons
DK166357C (da) Partikler med immunogene egenskaber svarende til hbs antigen samt vektorer og animalske celler til produktion af saadanne partikler
NZ212937A (en) Omega interferons: production by recombinant dna processes; pharmaceutical compositions
EP0835661A3 (en) Human interferon-Beta2A for use as a medicament
ES499289A0 (es) Procedimiento para la preparacion de un plasmido que codifica para la secuencia de aminoacidos del interferon de fibro- blastos humanos.
EP0072541A3 (en) Human leukocyte interferons, process for their microbial production, intermediates therefor and compositions containing them